You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Litigation Details for Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)

Docket   Start Trial Date Filed 2015-11-04
Court District Court, D. Delaware Date Terminated 2018-05-08
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Patents 6,572,497; 8,017,150; 8,475,832; 8,557,283; 8,603,514
Attorneys Andrew D. Regan; Bennet J. Moskowitz; Bindu Ann George Palapura; Cassandra A Adams; Charanjit Brahma; Craig C. Crockett; Dana Kathryn Severance; Daniel A. Ladow; Daniel Marcus Attaway; Daniel Sharpe; David Ellis Moore; David M. Airan; David M. Hanna; Dominick T. Gattuso; Elham F. Steiner; Elizabeth M. Crompton; Gregory C. Bays; J. Karl Gross; J. Magnus Essunger; James F. Hibey; James M. Bollinger; Jeffrey B. Elikan; Jeffrey H. Lerner; Katherine Harihar; Mary W. Bourke; Nellie J. Amjadi; Nicholas F. Lenning; Nicole E. Kopinski; Puja Patel Lea; R. Jason Fowler; Rachel M. Hofstatter; Steven H. Sklar; Sujatha Vathyam; Timothy C. Bickham; Timothy P. Heaton; Tung-On Kong
Firms Heyman Enerio Gattuso & Hirzel LLP; Womble Bond Dickinson (US) LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Indivior Inc. v. Mylan Technologies Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Indivior Inc. v. Mylan Technologies Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2020-04-23 329 Opinion - Memorandum Opinion trial: U.S. Patent Nos. 8,603,514 (“the ’514 patent”) and 8,900,497 (“the ’497 patent”). (D.I. 312 at…Fitness, LLC v. ICON Health & Fitness, Inc., 572 U.S. 545, 554 (2014). When considering whether a …the plaintiff brought it in subjective bad faith.” 572 U.S. at 555. Instead, the Supreme Court held that…to justify an award of attorney fees under § 285. 572 U.S. at 546 (“[A] district court may award fees … which the case was litigated.” Octane Fitness, 572 U.S. at 554. Therefore, I will not grant attorneys External link to document
2015-11-04 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,475,832; 8,017,150; 8,603,514… 4 November 2015 1:15-cv-01016-RGA Patent None District Court, D. Delaware External link to document
2017-01-12 87 Memorandum Opinion ;832 Patent"), U.S. Patent No. 8,017,150 (the '"150 Patent"), and U.S. Patent No. …multiple terms in dispute in U.S. Patent Nos. 8,603,514, 8,475,832, 8,017,150, and 8,900,497. Within five days…multiple terms in U.S. Patent No. 8,603,514 (the '"514 Patent"), U.S. Patent No. 8,475,832 (the…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.